Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 6:26 pm Sale |
2021-12-31 | 13G | FIVE PRIME THERAPEUTICS INC FPRX |
Rock Springs Capital Management LP | 0 0.000% |
-3,041,559 (Position Closed) |
Filing History |
| 2021-05-17 4:34 pm Sale |
2021-05-17 | 13G | FIVE PRIME THERAPEUTICS INC FPRX |
RA Capital Management, L.P. | 0 0.000% |
-4,285,161 (Position Closed) |
Filing History |
| 2021-03-15 06:33 am Purchase |
2021-03-08 | 13D | FIVE PRIME THERAPEUTICS INC FPRX |
Magnetar Financial LLC | 2,443,768 5.320% |
2,443,768 (New Position) |
Filing History |
| 2021-03-08 4:54 pm Purchase |
2021-03-04 | 13G | FIVE PRIME THERAPEUTICS INC FPRX |
BIOTECHNOLOGY VALUE FUND L P | 6,338,678 13.800% |
3,200,000 (+101.95%) |
Filing History |
| 2021-03-01 5:00 pm Purchase |
2021-02-18 | 13G | FIVE PRIME THERAPEUTICS INC FPRX |
Rock Springs Capital Management LP | 3,041,559 6.930% |
3,041,559 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | FIVE PRIME THERAPEUTICS INC FPRX |
RA Capital Management, L.P. | 4,285,161 9.800% |
4,285,161 (New Position) |
Filing History |
| 2021-02-16 10:26 am Purchase |
2020-12-31 | 13G | FIVE PRIME THERAPEUTICS INC FPRX |
RTW Investments, LP | 2,515,788 5.730% |
2,515,788 (New Position) |
Filing History |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | FIVE PRIME THERAPEUTICS INC FPRX |
BLACKROCK INC BLK |
2,959,031 6.700% |
833,854 (+39.24%) |
Filing History |
| 2021-02-01 5:19 pm Purchase |
2021-01-22 | 13G | FIVE PRIME THERAPEUTICS INC FPRX |
BIOTECHNOLOGY VALUE FUND L P | 3,138,678 7.200% |
1,875,000 (+148.38%) |
Filing History |
| 2020-12-08 4:56 pm Sale |
2020-11-30 | 13G | FIVE PRIME THERAPEUTICS INC FPRX |
BLACKROCK INC BLK |
2,125,177 4.800% |
-410,642 (-16.19%) |
Filing History |
| 2020-11-13 5:27 pm Sale |
2020-11-11 | 13D | FIVE PRIME THERAPEUTICS INC FPRX |
BIOTECHNOLOGY VALUE FUND L P | 1,263,678 3.300% |
-7,100,675 (-84.89%) |
Filing History |
| 2020-10-08 5:26 pm Purchase |
2020-10-06 | 13D | FIVE PRIME THERAPEUTICS INC FPRX |
BIOTECHNOLOGY VALUE FUND L P | 8,364,353 22.800% |
581,352 (+7.47%) |
Filing History |